z-logo
open-access-imgOpen Access
Prototype Smartphone-Based Device for Flow Cytometry with Immunolabeling via Supra-nanoparticle Assemblies of Quantum Dots
Author(s) -
Zhujun Xiao,
Ghinwa H. Darwish,
Kimihiro Susumu,
Igor L. Medintz,
W. Russ Algar
Publication year - 2021
Publication title -
acs measurement science au
Language(s) - English
Resource type - Journals
ISSN - 2694-250X
DOI - 10.1021/acsmeasuresciau.1c00033
Subject(s) - microfluidics , context (archaeology) , computer science , immunolabeling , quantum dot , nanotechnology , biomedical engineering , materials science , engineering , pathology , biology , medicine , paleontology , immunohistochemistry
Methods for the detection, enumeration, and typing of cells are important in many areas of research and healthcare. In this context, flow cytometers are a widely used research and clinical tool but are also an example of a large and expensive instrument that is limited to specialized laboratories. Smartphones have been shown to have excellent potential to serve as portable and lower-cost platforms for analyses that would normally be done in a laboratory. Here, we developed a prototype smartphone-based flow cytometer (FC). This compact 3D-printed device incorporated a laser diode and a microfluidic flow cell and used the built-in camera of a smartphone to track immunofluorescently labeled cells in suspension and measure their color. This capability was enabled by high-brightness supra-nanoparticle assemblies of colloidal semiconductor quantum dots (SiO 2 @QDs) as well as a support vector machine (SVM) classification algorithm. The smartphone-based FC device detected and enumerated target cells against a background of other cells, simultaneously and selectively counted two different cell types in a mixture, and used multiple colors of SiO 2 @QD-antibody conjugates to screen for and identify a particular cell type. The potential limits of multicolor detection are discussed alongside ideas for further development. Our results suggest that innovations in materials and engineering should enable eventual smartphone-based FC assays for clinical applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here